Paul Shapiro, PhD, and Jeffrey Hasday, MD, are developing a class of drugs that may be able to reset the natural balance of inflammation and prevent a number of serious diseases.

The Mass Spectrometry Center at UMSOP is a collaborative hub where cutting-edge instrumentation and scientific expertise come together to solve complex research challenges and support groundbreaking discoveries across the globe.

Researchers are developing a novel therapy using safe, drug-free nanoparticles to aid the body in fighting sepsis more effectively.

Allan Doctor, MD, of the School of Medicine and Joga Gobburu, PhD, MBA, of the School of Pharmacy are optimistic they are on the cusp of developing the world’s first viable artificial blood.

Ceremonies honor six academic programs and the next generation of health care leaders, researchers, and advocates .

Exciting exhibition reaffirms the School’s commitment to scholarly inquiry across disciplines.

Leadership role provides oversight for grant and contract submissions and identification of funding sources and initiates collaborative and translational research programs.

New study sheds light on how disease progression and biomolecular corona affect nanoparticle-mediated immune activation.

At the intersection of pharmacy and health economics, new fellowship program provides real-world experience for PhD students seeking to improve patient outcomes.

Six student teams presented issues, findings, and solutions in annual competition focused on promoting interest in regulatory science.

Kimberly Claeys, PharmD, PhD, an infectious disease pharmacist, will lead a multidisciplinary team focused on incorporating the 4Ms of age-friendly care to improve clinician workflow and patient outcomes in older adults with suspected UTI.

James Polli and Lisa Lebovitz received honors at the AACP Annual Meeting in July.